Categories
Stocks News Business News Global News Market News Earnings News IPO News
Quick Links
Ongoing IPO's Upcoming IPO's Closed IPO's Research Call's

kakinada

  1. K

    Aurobindo Pharma to Boost Penicillin G Output Beyond 10,000 MT Annually, Targets 20 to 21% EBITDA Margin in FY26

    Penicillin G Expansion Gains Momentum in Kakinada SEZ Aurobindo Pharma is stepping up its Penicillin G production, with plans to manufacture more than 10,000 metric tonnes annually over the next 12 months, according to Chief Financial Officer S Subramanian.The Hyderabad-based pharmaceutical...
    • Karthik
    • Thread
    • andhra pradesh api manufacturing aurobindo pharma china manufacturing ebitda generic pharmaceuticals kakinada manufacturing capacity market expansion penicillin-g pharmaceutical manufacturing regulatory approvals revenue growth rs 8,646 crore sez
    • Replies: 0
    • Forum: Business
Back
Top